What are the conservative management options for endometriosis, including analgesia and hormonal suppression to preserve fertility?

Conservative Management of Endometriosis

For pain relief in endometriosis, start with combined oral contraceptives or the 52mg levonorgestrel-releasing intrauterine system as first-line hormonal therapy, supplemented with NSAIDs for analgesia. 1, 2

First-Line Hormonal Suppression

The evidence strongly supports hormonal therapy as the primary conservative approach:

• Combined hormonal contraceptives (CHCs) are effective for pain relief and may be equivalent to more costly regimens 1
• Oral or depot medroxyprogesterone acetate demonstrates efficacy compared to placebo 1
• 52mg levonorgestrel-releasing IUS is specifically recommended as first-line treatment 2

These options reduce lesion size through hormonal suppression, though no medical therapy eradicates endometriosis lesions completely 1. The German-Austrian-Swiss guideline (2025) now emphasizes primary hormone treatment as the first-choice approach before considering surgical intervention 3.

Analgesia

NSAIDs (nonsteroidal anti-inflammatory drugs) are recommended for pain management and have been shown to reduce lesion size 1. They should be used in combination with hormonal therapy for optimal symptom control.

Second-Line Options

When first-line therapies fail:

• GnRH agonists for ≥3 months or danazol for ≥6 months are equally effective (Level A evidence) 1
• GnRH agonists with add-back therapy prevent bone mineral loss without reducing pain relief efficacy 1
• GnRH agonists can be used even without surgical confirmation of endometriosis if detailed evaluation excludes other causes of pelvic pain 1

Recent evidence (2026) confirms that oral GnRH antagonists offer advantages including rapid action, no flare effect, and dose-adjustable suppression, though hypoestrogenic side effects require monitoring 4.

Critical Fertility Considerations

Medical therapy does NOT improve fertility outcomes 1, 2. The evidence is clear:

• No medical treatment affects future fertility in women with endometriosis 1
• Antigonadotrophic hormonal therapy is not recommended for patients with endometriosis and infertility 2
• Studies lack evidence that absence of treatment causes fertility decline 1

For women desiring pregnancy, consider egg preservation before initiating treatment, particularly in those with endometriomas 5, 2.

Expectant Management

For asymptomatic patients, expectant management is appropriate since endometriosis is unpredictable and may regress spontaneously 1. Treatment should only be pursued when the disease has functional impact 2.

Treatment Algorithm

1. Symptomatic patients not desiring pregnancy:

   • Start CHCs or 52mg LNG-IUS + NSAIDs
   • Continue if effective
   • If inadequate response: Switch to alternative progestin or add GnRH agonist with add-back therapy

2. Symptomatic patients desiring pregnancy:

   • Discuss fertility preservation options first
   • NSAIDs for pain only
   • Avoid hormonal suppression
   • Consider surgical referral if conservative management fails

3. Severe or multiorgan disease:

   • Medical treatment alone may be insufficient 1
   • Requires multidisciplinary team evaluation 2

Important Caveats

• Symptom recurrence is common: Up to 44% experience recurrence within one year after any intervention 1
• Hormonal therapy provides temporary relief only: Symptoms typically return after discontinuation 6
• Postoperative hormonal suppression (if surgery becomes necessary) decreases recurrence and should be modified according to disease severity and fertility goals 5, 2
• No treatment prevents disease progression in terms of anatomic extent 1

The depth of endometriosis lesions correlates with pain severity, not the type or number of lesions 1. This explains why response to medical therapy varies significantly between patients.